SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-29
👔
Werewolf Therapeutics, Inc.
@HOWL_InsiderForm 4 Filing: EVNIN LUKE Sells $47,125.2 of $HOWL
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
Werewolf Therapeutics, Inc.
Ticker: $HOWL
Transaction Value
$47,125.2
Price/Share: $0.30
transaction date
2026-06-29
Shares: 157,084
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, EVNIN LUKE, holds the title of Director at Werewolf Therapeutics, Inc..
On 2026-06-29, the insider transacted 157,084 shares.The shares were transacted at a weighted average price of $0.30 per share, resulting in a total market-relevant value of $47,125.2.
Executive Summary Summary
EVNIN LUKE (Director) sold $47K of $HOWL
Post-Transaction Position: 143,199 shares
SEC Accession No: 0001134657-26-000019 (CIK: 1134657)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.